FindA University Ltd Featured PhD Programmes
Imperial College London Featured PhD Programmes
FindA University Ltd Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Surrey Featured PhD Programmes
"information" AND "studie…×
10 miles

Pharmacology / Toxicology (information studies) PhD Projects, Programs & Scholarships

We have 31 Pharmacology / Toxicology (information studies) PhD Projects, Programs & Scholarships

  • "information" AND "studies" ×
  • Pharmacology / Toxicology×
  • clear all
Order by 
Showing 1 to 10 of 31
  Development of novel cancer treatments: structural studies of Nectin 4 in complex with bespoke anti-cancer peptides – to start October 2019 - for an MSc by Dissertation (MSD)
  Dr F Prischi, Dr V Bavro
Application Deadline: 1 July 2019

Funding Type

PhD Type

Scientific background. This project targets the current gap in therapeutic approaches targeting Triple Negative Breast Cancer (TNBC) that, unlike other breast cancer subtypes, lacks recommended chemotherapy treatment.
  Multidisciplinary approach to understand how a pregnant woman’s lifestyle affects her child’s health.
  Prof P A Fowler, Dr S Bhattacharya
Application Deadline: 28 June 2019

Funding Type

PhD Type

The unborn baby is exposed to many environmental toxins in the mother’s womb and these can have lasting effects on their health in the future.
  Inhibition of PRMT5 as a cancer therapy
  Dr K. Sheppard, Prof G. McArthur
Applications accepted all year round

Funding Type

PhD Type

Targeted therapy has had profound impact on outcomes for cancer patients.
  Ensuring chemical safety through toxicity studies in Daphnia using state-of-the-art molecular, imaging and modelling approaches
  Prof M Viant, Dr B Campos, Dr C Rivetti, Dr I Sorrell
Application Deadline: 5 July 2019

Funding Type

PhD Type

This exciting 4-year BBSRC iCASE PhD opportunity bridges the University of Birmingham’s (*) metabolomics team and Unilever’s Safety and Environmental Assurance Centre (SEAC), both having state-of-the-art facilities and renowned research programmes, thereby creating an excellent environment for this challenging yet impactful research project.
  Fully Funded Public Health England PhD Scholarship: Use of advanced multi-cellular models of the human respiratory system to investigate the mechanistic effects of particulate and gaseous air pollutants
  Dr M Clift
Application Deadline: 21 June 2019

Funding Type

PhD Type

This scholarship is funded by Public Health England (PHE). Start date. October 2019. Subject areas. In Vitro Systems; In Vivo Models; Cell Biology; Cell Culture; Toxicology; Air Pollution; Particulate; NO2.
  Using optogenetics to understand memory retrieval in models relevant to Alzheimer’s disease
  Dr S Wang, Dr K Horsburgh
Application Deadline: 30 June 2019

Funding Type

PhD Type

Memory dysfunction is a hallmark in Alzheimer’s disease (AD) that significantly affects the daily life in people living with AD. It remains debated whether memory deficits reflect an inability to store the information or an inability to retrieve information that is previously stored.
  Defining the role of p53 in cancer immunotherapy
  Prof Y. Haupt, Dr S. Haupt, Dr P. Neeson
Applications accepted all year round

Funding Type

PhD Type

Despite clear evidence of an association between the tumour suppressor p53 and immunity, a gap in knowledge exists regarding its role in modulating immune responses, or its value in predicting patient responses to immunotherapy.
  Development of targeted therapy for acute myeloid leukaemia with mutations in isocitrate dehysdrogenase
  Dr L. Kats
Applications accepted all year round

Funding Type

PhD Type

Acute Myeloid Leukaemia (AML) is an aggressive disease with poor prognosis and development of novel treatment options is urgently needed.
  Exploration of novel approaches to anti-cancer treatment: manipulation of mutant p53
  Prof Y. Haupt, Dr S. Haupt
Applications accepted all year round

Funding Type

PhD Type

P53 is the most mutated gene in human cancer, affecting about half the cases of human cancer. We have recently identified novel regulators of mutant p53 using sophisticated loss of function whole genome high through put screen (image 1).
  Impact of targeted therapy on the melanoma immune microenvironment
  Dr K. Sheppard, Prof G. McArthur
Applications accepted all year round

Funding Type

PhD Type

The treatment of melanoma is undergoing a fundamental change due to the success of both targeted therapies directed at the MAPK/ERK pathway and immunotherapies.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.